Royce & Associates LP Sells 38,447 Shares of Transcat, Inc. (NASDAQ:TRNS)

Royce & Associates LP lowered its position in Transcat, Inc. (NASDAQ:TRNS) by 7.5% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 473,254 shares of the scientific and technical instruments company’s stock after selling 38,447 shares during the quarter. Royce & Associates LP owned approximately 0.05% of Transcat worth $50,042,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of TRNS. Jones Financial Companies Lllp lifted its stake in Transcat by 686.7% in the 4th quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company’s stock worth $37,000 after purchasing an additional 309 shares in the last quarter. Morgan Dempsey Capital Management LLC purchased a new stake in Transcat in the 4th quarter worth $143,000. Captrust Financial Advisors purchased a new stake in Transcat in the 3rd quarter worth $201,000. SG Americas Securities LLC purchased a new stake in Transcat in the 4th quarter worth $182,000. Finally, Walleye Capital LLC purchased a new stake in Transcat in the 3rd quarter worth $216,000. Institutional investors own 98.34% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the stock. Craig Hallum upped their target price on shares of Transcat from $113.00 to $125.00 and gave the company a “buy” rating in a research report on Thursday, December 12th. HC Wainwright decreased their target price on shares of Transcat from $126.00 to $106.00 and set a “buy” rating on the stock in a research report on Wednesday, January 29th. StockNews.com cut shares of Transcat from a “hold” rating to a “sell” rating in a research report on Wednesday, February 5th. Northland Securities restated a “market perform” rating and set a $85.00 target price (down from $110.00) on shares of Transcat in a research report on Wednesday, January 29th. Finally, Oppenheimer downgraded shares of Transcat from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 29th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, Transcat presently has a consensus rating of “Hold” and a consensus target price of $111.50.

Insider Activity at Transcat

In other news, Director Craig D. Cairns bought 1,200 shares of the firm’s stock in a transaction that occurred on Friday, January 31st. The stock was bought at an average price of $77.02 per share, with a total value of $92,424.00. Following the completion of the transaction, the director now directly owns 1,910 shares of the company’s stock, valued at approximately $147,108.20. The trade was a 169.01 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 2.30% of the stock is currently owned by corporate insiders.

Transcat Price Performance

Shares of TRNS stock opened at $72.57 on Friday. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.42 and a quick ratio of 1.98. The company’s 50-day simple moving average is $86.32 and its two-hundred day simple moving average is $104.38. Transcat, Inc. has a one year low of $70.47 and a one year high of $147.12. The company has a market capitalization of $675.55 million, a P/E ratio of 39.23 and a beta of 0.66.

Transcat (NASDAQ:TRNS) last released its quarterly earnings data on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.07. Transcat had a net margin of 6.22% and a return on equity of 7.23%. During the same quarter in the prior year, the firm earned $0.56 EPS. As a group, equities analysts anticipate that Transcat, Inc. will post 2.3 EPS for the current year.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.